Palmitoylethanolamide CAS: 544-31-0
MF: C18H37NO2
MW: 299.5
An endogenous cannabinoid agonist, FAAH inhibitor, and PPARα agonist.

Palmitoylethanolamide (CAS 544-31-0)

Palmitoylethanolamide | CAS 544-31-0 is rated 5.0 out of 5 by 1.
  • y_2020, m_8, d_2, h_15
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.10
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_202754, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 138ms
  • REVIEWS, PRODUCT
5
1
4
0
3
0
2
0
1
0
Alternate Names: PEA
Application: Palmitoylethanolamide is an endogenous cannabinoid agonist, FAAH inhibitor, and PPARα agonist
CAS Number: 544-31-0
Purity: >99%
Molecular Weight: 299.5
Molecular Formula: C18H37NO2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data (including water content).

Palmitoylethanolamide is an endogenous cannabinoid. It is a weak ligand of the cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptors. It has been found to inhibit FAAH (fatty acid amide hydrolase). Palmitoylethanolamide exhibits anti-nociceptive, anti-inflammatory, anti-convulsant and immunosuppresant activity. Palmitoylethanolamide acts by binding to an unidentified cannabinoid receptor that is similar to CB2. It also acts as a selective activator of the GPR55 receptor. In addition, this compound directly activates PPARα, producing an anti-inflammatory response.


References

1. Facci, L., et al. 1995. Proc. Natl. Acad. Sci. U.S.A. 92: 3376-3380. PMID: 7724569
2. Mazzari, S., et al. 1996. Eur. J. Pharmacol. 300: 227-236. PMID: 8739213
3. Cadas, H., et al. 1996. J. Neurosci. 16: 3934-3942. PMID: 8656287
4. Skaper, S.D., et al. 1996. Proc. Natl. Acad. Sci. U.S.A. 93: 3984-3989. PMID: 8633002
5. Lambert, D.M., et al. 1999. Biochim. Biophys. Acta. 1440: 266-274. PMID: 10521710
6. Jonsson, K.O., et al. 2001. Br. J. Pharmacol. 133: 1263-1275. PMID: 11498512
7. De Petrocellis, L., et al. 2002. Fundam Clin Pharmacol. 16: 297-302. PMID: 12570018

Physical State :
Solid
Solubility :
Soluble in DMSO (20 mM), ethanol (25 mM), chloroform, THF ( at 30° C), and DMF (~10 mg/ml).
Storage :
Store at -20° C
Melting Point :
98.5° C
Boiling Point :
461.47° C at 760 mmHg (Predicted)
Density :
0.91 g/cm3 (Predicted)
Refractive Index :
n20D 1.46 (Predicted)
IC50 :
GPR55: EC5050 = 4 nM; GB4 : IC50 = 501.19 nM (Plasmodium falciparum); PPARα: EC5050 = 3 µM; [3H]- AEA metabolism : IC50 = 5.01 µM (rat); Vanilloid receptor: EC5050 = >10 µM (human)
Ki Data :
CB1: Ki= >5 µM (human); CB2: Ki= >5 µM (human)
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
WGK Germany :
2
RTECS :
ML8950000
PubChem CID :
4671
Merck Index :
14: 6995
MDL Number :
MFCD00020562
EC Number :
208-867-9
SMILES :
CCCCCCCCCCCCCCCC(=O)NCCO

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 116ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 5 out of 5 by from Aghaei Aghaei, I. et al. (PubMed 26370914) reported that Palmitoylethanolamide attenuates PTZ-induced seizures through CB1 and CB2 receptors in male wistar rats. -SCBT Publication Review
Date published: 2015-05-21
  • y_2020, m_8, d_2, h_15
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.10
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_202754, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 11ms
  • REVIEWS, PRODUCT

Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.